Tyenne Tocilizumab-Aazg Injection 200/10 mL (20 mg/mL) Single-Dose Vial, Preservative Free 10 mL (RX)
How to Order:
You will receive instructions on how to create an account along with Rx Ordering Details.
(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Top-Performing Biologic Treatment for Rheumatoid Arthritis & Autoimmune Diseases
Experience advanced relief from chronic inflammation and joint pain with Tyenne Tocilizumab-Aazg, a biosimilar to Actemra and an industry-leading injectable biologic for autoimmune and inflammatory disorders. Manufactured by Fresenius Kabi, this preservative-free, single-dose vial offers a powerful solution for adults suffering from moderately to severely active rheumatoid arthritis (RA).
What is Tyenne Tocilizumab-Aazg Used For?
Tyenne (tocilizumab-aazg) belongs to a class of interleukin-6 (IL-6) receptor antagonists and is FDA-approved for the treatment of:
- Moderate to Severe Rheumatoid Arthritis (RA): For adults with inadequate response to one or more Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Autoimmune & Inflammatory Diseases: Targeted therapy for unresponsive or complex autoimmune conditions
Who Needs Tyenne Tocilizumab-Aazg?
- Adults diagnosed with moderate to severe rheumatoid arthritis
- Patients who have not achieved sufficient relief with traditional DMARDs (Methotrexate, Sulfasalazine)
- Individuals requiring advanced immunosuppressive biologic therapy for chronic joint pain, swelling, and autoimmune inflammation
Key Features & Health Benefits
- Biosimilar to Actemra – Clinically Proven Efficacy
- Reduces Inflammation, Joint Pain, Stiffness & Swelling
- Slows Disease Progression & Joint Damage
- Single-Dose, Preservative-Free Vial for Safety & Convenience
- High-Quality Manufacturing by Fresenius Kabi
Dosing & Administration
- Standard Dose: 162 mg subcutaneous injection once every week with a tapering course of glucocorticoids.
- Alternate Dose: 162 mg every other week may be considered by your healthcare provider.
- Monotherapy: Tyenne can be continued alone following discontinuation of glucocorticoids.
Health Category
- Biologic Drugs for Autoimmune Disease
- Rheumatoid Arthritis Treatments
- Immunomodulatory & Anti-Inflammatory Medications
NDC: 65219-0592-10 UPC: 365219592105
Related RX Products
- Actemra (tocilizumab)
- Humira (adalimumab)
- Enbrel (etanercept)
- Orencia (abatacept)
- Simponi (golimumab)
- Methotrexate (oral/injectable)
- Xeljanz (tofacitinib)
Possible Side Effects
Common Side Effects:
- Injection site reactions (redness, pain, swelling, itching)
- Upper respiratory infections (sinus, throat)
- Headache
- High blood pressure (hypertension)
- Increased liver enzymes
Serious Risks:
- Serious infections due to reduced immune response
- Increased cholesterol levels
- Liver dysfunction
- Allergic reactions (rash, swelling, trouble breathing)
Seek emergency medical attention for any severe or unusual symptoms. Always discuss benefits, risks, and monitoring requirements with your healthcare provider before starting Tyenne.
Order Tyenne Tocilizumab-Aazg for Advanced Arthritis Relief
Regain control of your health and manage rheumatoid arthritis effectively with Tyenne Tocilizumab-Aazg Injection—the trusted and clinically proven biosimilar for lasting inflammation and pain relief. Order online today or consult your healthcare professional about Tyenne from Fresenius Kabi.
